Form 4 filed by Garland J. Scott
Garland J. Scott filed this Form 4 on Enliven Therapeutics, Inc. with 3 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-05 20:57:04 UTC.
- Accession
- 0001533228-26-000009
- Filer
- CIK 1533228
- Filed
- 2026-10-05
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: Enliven Therapeutics, Inc. (CIK 1672619)
- Garland J. Scott director
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-01 | M exercised | +13,000 | $15.47 | 13,000 | D |
| Common Stock | 2026-10-01 | S sold | -13,000 | $46.6707 | 0 | D |
| Stock Option (right to buy) derivative | 2026-10-01 | M exercised | -13,000 | $0 | 46,372 | D |